All I know is she found me on Instagram literal years ago and told me about this movie she was making that centers the ...

Researchers at Kennedy Krieger Institute’s International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...

“The perception of the public is that it’s just about paralysis but actually it’s way more than that. People with spinal cord ...

Researchers at Kennedy Krieger Institute report that Transcutaneous Spinal Cord Stimulation (TSS) combined with movement ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...

Tim Brodigan was told he wouldn't walk again after the 2017 Amtrak derailment near DuPont. Nearly 7 years later, he is able ...

Natalie Barnhard Catstrogiovanni founded her center for those recovering from traumatic injury. 20-years after her injury, ...

The Duke and Duchess of Edinburgh paid tribute to Stoke Mandeville Hospital’s National Spinal Injuries Centre as it celebrates its 80th year.

Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury (SCI) is approaching completion NVG-300 preclinical test-of-concept studies ...

The webcast will be held on November 26, 2024, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver who will discuss highlights from Q3 2024 and provide a business update. To join the ...

This designation supports the development of ExoPTEN and opens a pathway for faster entry into European markets, where the Company expects demand for effective spinal cord injury therapies to be high.